Improving management of celiac disease with new gluten detection technologies
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
This study is exploring new ways to help adults with celiac disease manage their condition better by using handy gluten detection tools and telemedicine to make it easier for them to connect with dietitians and stay on track with their gluten-free diet.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10924061 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of innovative gluten detection technologies combined with telemedicine to enhance the management of celiac disease in adults. Celiac disease, affecting about 1% of the U.S. population, can lead to severe health issues if not properly managed. The study aims to facilitate better communication between patients and dietitians through telemedicine, while also empowering patients with tools for self-monitoring gluten exposure. By utilizing portable gluten sensors and urine tests, the research seeks to improve adherence to a gluten-free diet and overall quality of life for those affected.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with celiac disease who are seeking better management strategies.
Not a fit: Patients who do not have celiac disease or are not interested in using technology for self-monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the management of celiac disease, leading to better health outcomes and quality of life for patients.
How similar studies have performed: Previous research has shown promising results with telemedicine and self-monitoring technologies in managing chronic conditions, indicating potential success for this approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Lebwohl, Benjamin — Columbia University Health Sciences
- Study coordinator: Lebwohl, Benjamin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.